Cargando…
Italian guidelines for the management and treatment of neonatal cholestasis
Hyperbilirubinemia is a frequent condition affecting newborns during the first two weeks of life and when it lasts more than 14 days it is defined as prolonged jaundice. This condition requires differential diagnosis between the usually benign unconjugated hyperbilirubinemia and the pathological con...
Autores principales: | Dani, Carlo, Pratesi, Simone, Raimondi, Francesco, Romagnoli, Costantino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591626/ https://www.ncbi.nlm.nih.gov/pubmed/26428285 http://dx.doi.org/10.1186/s13052-015-0178-7 |
Ejemplares similares
-
Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
por: Romagnoli, Costantino, et al.
Publicado: (2014) -
Parenteral nutrition associated cholestasis
por: Costa, Simonetta, et al.
Publicado: (2015) -
Unexpected episodes of cyanosis in late preterm and term neonates prompted admission to a neonatal care unit
por: Dani, Carlo, et al.
Publicado: (2017) -
Neurotoxicity of Unconjugated Bilirubin in Neonatal Hypoxic-Ischemic Brain Injury in vitro
por: Dani, Carlo, et al.
Publicado: (2021) -
Neonatal Cholestasis: A Pandora’s Box
por: Pandita, Aakash, et al.
Publicado: (2018)